All In MedTech

FDA Clearance Tracker · P240043

DIAM­™ Spinal Stabilization System

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Dec 10, 2025 (this decision)Source: openFDAMethods & limitations

PMABreakthrough

Decided

Dec 10, 2025

Approved

Time to decision

369 days

Received Dec 6, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P240043
Device name
DIAM­™ Spinal Stabilization System
Applicant location
Merignac
Received
Dec 6, 2024
Decided
Dec 10, 2025
Decision
Approved
Supplements
1 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code NQO

FDA's approval statement

As written in FDA's record.

The DIAM™ Spinal Stabilization System is indicated for skeletally mature patients that have moderate to severe primary low back pain (greater than leg pain) secondary to lumbar degenerative disc disease (DDD), at a single level from L2-L5 with current episode refractory to at least 6 months of non-operative care.Symptomatic disc disease is confirmed by patient history, physical examination, and radiographic evaluation with one or more of the following factors:• Greater than 2mm of decreased disc height (average disc height) compared to the adjacent level• Scarring/thickening of the ligamentum flavum, annulus fibrosus, or facet joint capsule • Non-extruded herniated nucleus pulposusThe DIAM™ device is implanted via a minimally invasive posterior approach.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NQO. The earliest in FDA's data is P040001, decided Nov 21, 2005.
  • It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).

Source documents

Other decisions for Companion Spine France Sas

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.